New insights from DESTINY-Breast04 highlight how trastuzumab deruxtecan (T-DXd) not only extends survival but also delays symptom deterioration in HER2-…
AudioAbstracts
AudioAbstracts by ReachMD provides an easy-to-digest distillation of important medical literature in combination with digital linkage to in-depth information supporting the audio synopsis. AudioAbstracts harnesses the ReachMD digital network to broadcast the spoken synopsis and related digital links through its on-air, online, onsite, and mobile distribution network. Combining quick-read audio synopses with links to source material, AudioAbstracts is the smarter, faster way to stay current on medical literature.
- Update frequency
- every 71 days
- Episodes
- 48
- Years Active
- 2015 - 2025
DESTINY-Breast04 Findings: T-DXd and Quality of Life in HER2-Low Metastatic Breast Cancer
Host: Marlene Mimi Maeusli, PhD.
Thu 31 Jul 2025
DESTINY-Breast04 Findings: T-DXd and Quality of Life in HER2-Low Metastatic Breast Cancer
Host: Marlene Mimi Maeusli, PhD.
New insights from DESTINY-Breast04 highlight how trastuzumab deruxtecan (T-DXd) not only extends survival but also delays symptom deterioration in HER2-…
Thu 31 Jul 2025
Assessing Sex-Based Treatment Responses to Gepants In Migraine Management
A secondary analysis of eight clinical trials assessed the efficacy of ubrogepant and atogepant in both acute and preventive migraine treatments. Dive into these findings and explore implications for…
Fri 11 Jul 2025
Assessing Sex-Based Treatment Responses to Gepants In Migraine Management
A secondary analysis of eight clinical trials assessed the efficacy of ubrogepant and atogepant in both acute and preventive migraine treatments. Dive into these findings and explore implications for…
Fri 11 Jul 2025
Exploring the ACE Index in Acute Ulcerative Colitis
Host: Esteban Figueroa, MD
Exploring the ACE Index in Acute Ulcerative Colitis
Rebecca K Grant, Gareth-Rhys Jones, Nikolas Plevris, Ruairi W Lynch, Philip W Jenkinson, Charlie W Lees, Tho…
Tue 29 Mar 2022
Exploring the ACE Index in Acute Ulcerative Colitis
Host: Esteban Figueroa, MD
Exploring the ACE Index in Acute Ulcerative Colitis
Rebecca K Grant, Gareth-Rhys Jones, Nikolas Plevris, Ruairi W Lynch, Philip W Jenkinson, Charlie W Lees, Tho…
Tue 29 Mar 2022
A Specific Mutation in Muc2 Determines Early Dysbiosis in Colitis-Prone Winnie Mice
Host: Ivy Ka Man Law, PhD
A Specific Mutation in Muc2 Determines Early Dysbiosis in Colitis-Prone Winnie Mice
Marina Liso, Stefania De Santis, Giulio Verna, Manuela Dicarlo, Maria Calasso, …
Thu 30 Jul 2020
A Specific Mutation in Muc2 Determines Early Dysbiosis in Colitis-Prone Winnie Mice
Host: Ivy Ka Man Law, PhD
A Specific Mutation in Muc2 Determines Early Dysbiosis in Colitis-Prone Winnie Mice
Marina Liso, Stefania De Santis, Giulio Verna, Manuela Dicarlo, Maria Calasso, …
Thu 30 Jul 2020
Proactive vs. Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s Disease
Host: Abdullah Abdussalam, MD
Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s
Diana M Negoescu, Eva A Enns, PhD, Brooke Swanhorst, Bonnie Baumgartner, James P Ca…
Wed 22 Jul 2020
Proactive vs. Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s Disease
Host: Abdullah Abdussalam, MD
Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s
Diana M Negoescu, Eva A Enns, PhD, Brooke Swanhorst, Bonnie Baumgartner, James P Ca…
Wed 22 Jul 2020
Real-World Pattern of Biologic Use in Patients with Inflammatory Bowel Disease
Guest: Anish Patel, DO, FACG
Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive…
Wed 18 Mar 2020
Real-World Pattern of Biologic Use in Patients with Inflammatory Bowel Disease
Guest: Anish Patel, DO, FACG
Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive…
Wed 18 Mar 2020
Improving the Quality of Inpatient Ulcerative Colitis Management
Guest: Robin Dalal, MD
Improving the Quality of Inpatient Ulcerative Colitis Management: Promoting Evidence-Based Practice and Reducing Care Variation With an Inpatient Protocol
Fri 06 Mar 2020
Improving the Quality of Inpatient Ulcerative Colitis Management
Guest: Robin Dalal, MD
Improving the Quality of Inpatient Ulcerative Colitis Management: Promoting Evidence-Based Practice and Reducing Care Variation With an Inpatient Protocol
Fri 06 Mar 2020
Assessing the Correlation Between Perianal Fistula Healing & Trough Levels of Infliximab in Children with IBD
Host: Alka Goyal, MD
Higher Postinduction Infliximab Serum Trough Levels Are Associated With Healing of Fistulizing Perianal Crohn’s Disease in Children.
Wed 19 Jun 2019
Assessing the Correlation Between Perianal Fistula Healing & Trough Levels of Infliximab in Children with IBD
Host: Alka Goyal, MD
Higher Postinduction Infliximab Serum Trough Levels Are Associated With Healing of Fistulizing Perianal Crohn’s Disease in Children.
Wed 19 Jun 2019
Iron Sequestration in Microbiota Biofilms in Treatment for IBD
Host: Damian Maseda, D.M.Sc., PhD
Iron Sequestration in Microbiota Biofilms As A Novel Strategy for Treating Inflammatory Bowel Disease.
Fri 29 Mar 2019
Iron Sequestration in Microbiota Biofilms in Treatment for IBD
Host: Damian Maseda, D.M.Sc., PhD
Iron Sequestration in Microbiota Biofilms As A Novel Strategy for Treating Inflammatory Bowel Disease.
Fri 29 Mar 2019
Disclaimer: The podcast and artwork embedded on this page are the property of ReachMD. This content is not affiliated with or endorsed by eachpod.com.